November 6, 2015
General
With a current caseload of over 50 million enrollees, and as one of the prime programs targeted for fraud nationally, the Medicare program has a lot on its plate. In today’s case, we review a recent Medicare settlement between the federal government, the state government of Maine, and a Portland-area […]
November 5, 2015
General
In one of the few False Claims Act cases to come out of South Dakota, two contractors related to the logging industry have agreed to pay $1.2 million to settle claims that they violated the terms of their agreement with the U.S. Forest Service and billed for the work nonetheless. […]
November 4, 2015
General
In a recent lawsuit filed under the state of New York’s False Claims Act, a former sales representative for BioMet, which has since merged with Zimmer Holdings, has alleged the company engaged in illegal and unlawful practices when touting its dental implant products. More specifically, the whistleblower’s complaint asserts that […]
November 3, 2015
General
Things may be looking up for Tuomey Healthcare System. Back in 2013, this South Carolina-based healthcare provider was slapped with an initial whopping $276 million fine regarding accusations of physician kickbacks. In a surprising turn of events, the Department of Justice recently announced that it settled with Tuomey for a […]
November 2, 2015
General
In a recent article published by the whistleblower advocacy organization Taxpayers Against Fraud (TAF), an unofficial tabulation of False Claims Act settlements shows a lucrative fiscal year with over $3 billion recovered on behalf of taxpayers, with $2 billion of that represented by whistleblower-initiated cases. FY 2015 saw many repeat […]
October 30, 2015
General
Following an intensive investigation into the practices of pharmaceutical giant Warner Chilcott U.S. Sales LLC, the company has agreed to settle criminal and civil allegations of healthcare fraud for $125 million as well as plead guilty to one felony count of healthcare fraud. In October 2015, the former president of […]
October 29, 2015
General
What is off-label marketing? When it comes to pharmaceutical marketing, it may seem like the options are virtually endless for a company seeking to boost sales and increase exposure of its product. However, despite the relentless television commercials and internet ads, there are a number of restrictions placed on the […]
October 28, 2015
General
With just one week before the start of a False Claims Act trial involving drug manufacturer Novartis Pharmaceuticals, the company decided to avoid the unpredictability of a jury in favor of a calculated $390 million settlement. The company is facing several False Claims Act lawsuits involving a number of different […]
October 27, 2015
General
In yet another case of defense contractor fraud, a company known as APL, Ltd. has agreed to pay $9.8 million to the federal government amid allegations of false billing. APL is a Scottsdale, Arizona-based subsidiary of Singapore’s Neptune Orient Lines Limited, a global shipping company engaged in the transcontinental transport […]
October 26, 2015
Canada News
Morganti Legal (Toronto) and Faguy & Co. (Montreal), announce that on Monday, October 26, 2015, they issued a class action claim in Quebec on behalf of all investors that purchased the securities of Valeant Pharmaceuticals International Inc. listed on the Toronto Stock Exchange and the Swiss Stock Exchange. (TSX and SIX: “VRX”). Investors […]
October 26, 2015
General
In some cases, a company facing possible liability under the False Claims Act may opt to self-report and self-disclose the potential violations, which typically results in a lesser fine and may help offset some of the statutory penalties awaiting violators of the Act. In today’s case, we review a recent […]
October 25, 2015
Canada News
Cy Moscow, partner of leading Detroit-based law firm Honigman Miller Schwartz & Cohn LLP and adjunct professor at University of Michigan School of Law, has once again invited Andrew Morganti to lecture to the third-year law students in his advanced securities regulations course on the topic of shareholders’ rights litigation […]